BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18618510)

  • 61. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status.
    Baser S; Shannon VR; Eapen GA; Jimenez CA; Onn A; Lin E; Morice RC
    Chest; 2006 Dec; 130(6):1784-90. PubMed ID: 17166997
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A comparison study of clinicopathologic characteristics of Southern California Asian American Non-small Cell Lung Cancer (NSCLC) patients by smoking status.
    Ou SH; Ziogas A; Zell JA
    J Thorac Oncol; 2010 Feb; 5(2):158-68. PubMed ID: 20040896
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Overestimating the influence of the 1999 WHO classification of lung tumors on survival in bronchioloalveloar carcinoma.
    Tsurutani J; Ballas MS; Dennis PA
    J Clin Oncol; 2006 Apr; 24(12):1963; author reply 1963-4. PubMed ID: 16622278
    [No Abstract]   [Full Text] [Related]  

  • 64. Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma.
    Shiba M; Kohno H; Kakizawa K; Iizasa T; Otsuji M; Saitoh Y; Hiroshima K; Ohwada H; Fujisawa T
    Cancer; 2000 Oct; 89(7):1457-65. PubMed ID: 11013358
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The influence of smoking intensity on the clinicopathologic features and survival of patients with surgically treated non-small cell lung cancer.
    Park SY; Lee JG; Kim J; Bae MK; Lee CY; Kim DJ; Chung KY
    Lung Cancer; 2013 Sep; 81(3):480-486. PubMed ID: 23896023
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Former smokers with non-small-cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis.
    Zheng S; Wang R; Zhang Y; Pan Y; Cheng C; Zheng D; Sun Y; Chen H
    Cancer Med; 2016 Aug; 5(8):2117-25. PubMed ID: 27227356
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinicopathologic aspects of oral leukoplakia in smokers and nonsmokers.
    Freitas MD; Blanco-Carrión A; Gándara-Vila P; Antúnez-López J; García-García A; Gándara Rey JM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Aug; 102(2):199-203. PubMed ID: 16876063
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Lung cancer in 1993].
    Steffensen IE; Faurschou P; Viskum K
    Ugeskr Laeger; 1994 May; 156(20):3013-7. PubMed ID: 8023406
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Nonsmall cell lung cancer in never smokers.
    Scagliotti GV; Longo M; Novello S
    Curr Opin Oncol; 2009 Mar; 21(2):99-104. PubMed ID: 19532009
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer.
    Vashi PG; Edwin P; Popiel B; Gupta D
    BMC Cancer; 2015 Dec; 15():1012. PubMed ID: 26704811
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group.
    Thunnissen E; Kerr KM; Herth FJ; Lantuejoul S; Papotti M; Rintoul RC; Rossi G; Skov BG; Weynand B; Bubendorf L; Katrien G; Johansson L; López-Ríos F; Ninane V; Olszewski W; Popper H; Jaume S; Schnabel P; Thiberville L; Laenger F
    Lung Cancer; 2012 Apr; 76(1):1-18. PubMed ID: 22138001
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Non-small cell lung cancer in never- and ever-smokers: Is it the same disease?
    Tang A; Ahmad U; Toth AJ; Bourdakos N; Raja S; Raymond DP; Blackstone EH; Murthy SC
    J Thorac Cardiovasc Surg; 2021 Jun; 161(6):1903-1917.e9. PubMed ID: 32893009
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of smoking on mortality of patients with non-small cell lung cancer.
    Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW
    Thorac Cancer; 2014 Jan; 5(1):43-9. PubMed ID: 26766971
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions.
    Pelosof L; Ahn C; Gao A; Horn L; Madrigales A; Cox J; McGavic D; Minna JD; Gazdar AF; Schiller J
    J Natl Cancer Inst; 2017 Jan; 109(7):. PubMed ID: 28132018
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Should cavitated bronchopulmonary cancers be considered a separate entity?
    Mouroux J; Padovani B; Elkaïm D; Richelme H
    Ann Thorac Surg; 1996 Feb; 61(2):530-2. PubMed ID: 8572761
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association between Expression of 8-OHdG and Cigarette Smoking in Non-small Cell Lung Cancer.
    An AR; Kim KM; Park HS; Jang KY; Moon WS; Kang MJ; Lee YC; Kim JH; Chae HJ; Chung MJ
    J Pathol Transl Med; 2019 Jul; 53(4):217-224. PubMed ID: 30853705
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers.
    Lee JY; Na II; Jang SH; Hwang YI; Choe du H; Kim CH; Baek H
    J Thorac Dis; 2013 Dec; 5(6):758-63. PubMed ID: 24409352
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A multi-omics study links TNS3 and SEPT7 to long-term former smoking NSCLC survival.
    Shen S; Wei Y; Li Y; Duan W; Dong X; Lin L; You D; Tardon A; Chen C; Field JK; Hung RJ; Liu G; Zhu D; Amos CI; Su L; Zhao Y; Hu Z; Shen H; Zhang R; Chen F; Christiani DC
    NPJ Precis Oncol; 2021 May; 5(1):39. PubMed ID: 34002017
    [TBL] [Abstract][Full Text] [Related]  

  • 79. RE: Proportion of Never-Smoker Non-Small Cell Lung Cancer Patients at Three Diverse Institutions.
    Page BJ; Bowman RV; Yang IA; Fong KM
    J Natl Cancer Inst; 2018 Apr; 110(4):432. PubMed ID: 29045674
    [No Abstract]   [Full Text] [Related]  

  • 80. Numbers and people.
    Feins E
    J Surg Educ; 2007; 64(3):187-8. PubMed ID: 17574183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.